These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7974897

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC, Mahendra V, Roberts JG.
    J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Tumor recurrence in the upper urinary tract after total cystectomy].
    Bouchot O, Zerbib M.
    Prog Urol; 2002 Nov; 12(5):1085-91. PubMed ID: 12536930
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Adenocarcinoma of the renal pelvis and transitional cell carcinoma of the ureter occurring 11 years after radical cystectomy for bladder cancer: a case report].
    Shishido T, Itou T, Ono Y, Arai Y, Miki M.
    Hinyokika Kiyo; 2001 Mar; 47(3):187-90. PubMed ID: 11329961
    [Abstract] [Full Text] [Related]

  • 8. [Risk of tumor seeding after nephroureterectomy combined with endoscopic resection of the ureteral meatus].
    Fernández Gómez JM, Barmadah SE, Pérez García J, Rábade Rey CJ, Rodríguez Martínez JJ.
    Arch Esp Urol; 1998 Oct; 51(8):829-31. PubMed ID: 9859592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M.
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [Abstract] [Full Text] [Related]

  • 11. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.
    Sved PD, Gomez P, Nieder AM, Manoharan M, Kim SS, Soloway MS.
    BJU Int; 2004 Oct; 94(6):785-9. PubMed ID: 15476508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE.
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [Abstract] [Full Text] [Related]

  • 14. [Recurrent urothelial cancer after resection of ureteral carcinoma].
    Kong C, Ci J, Liu T.
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy].
    Miyoshi Y, Asakura T, Matsuzaki J, Fukuda M, Satomi Y, Akabane H.
    Hinyokika Kiyo; 1996 Dec; 42(12):961-4. PubMed ID: 9013232
    [Abstract] [Full Text] [Related]

  • 18. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC, Lin AT, Chen KK, Chang LS.
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
    Hassan JM, Cookson MS, Smith JA, Johnson DL, Chang SS.
    J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.